GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Cyclically Adjusted Price-to-FCF

Bristol-Myers Squibb Co (BUE:BMY) Cyclically Adjusted Price-to-FCF : 10.76 (As of May. 24, 2024)


View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF?

As of today (2024-05-24), Bristol-Myers Squibb Co's current share price is ARS17392.00. Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ARS1,615.99. Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF for today is 10.76.

The historical rank and industry rank for Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BUE:BMY' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 9.12   Med: 24.17   Max: 40.86
Current: 9.12

During the past years, Bristol-Myers Squibb Co's highest Cyclically Adjusted Price-to-FCF was 40.86. The lowest was 9.12. And the median was 24.17.

BUE:BMY's Cyclically Adjusted Price-to-FCF is ranked better than
89.74% of 312 companies
in the Drug Manufacturers industry
Industry Median: 33.315 vs BUE:BMY: 9.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bristol-Myers Squibb Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ARS1,061.975. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ARS1,615.99 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.21 20.69 17.41 18.54 11.69

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.83 15.49 13.48 11.69 11.91

Competitive Comparison of Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF falls into.



Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=17392.00/1615.99
=10.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bristol-Myers Squibb Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bristol-Myers Squibb Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1061.975/131.7762*131.7762
=1,061.975

Current CPI (Mar. 2024) = 131.7762.

Bristol-Myers Squibb Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 4.605 100.560 6.035
201409 4.013 100.428 5.266
201412 1.944 99.070 2.586
201503 2.579 99.621 3.411
201506 -0.512 100.684 -0.670
201509 1.625 100.392 2.133
201512 4.601 99.792 6.076
201603 -4.086 100.470 -5.359
201606 1.482 101.688 1.921
201609 9.444 101.861 12.218
201612 10.097 101.863 13.062
201703 5.259 102.862 6.737
201706 13.350 103.349 17.022
201709 15.457 104.136 19.560
201712 10.030 104.011 12.707
201803 11.500 105.290 14.393
201806 13.095 106.317 16.231
201809 23.730 106.507 29.360
201812 75.203 105.998 93.492
201903 28.321 107.251 34.797
201906 51.639 108.070 62.967
201909 80.980 108.329 98.507
201912 59.465 108.420 72.275
202003 103.110 108.902 124.768
202006 131.959 108.767 159.874
202009 68.534 109.815 82.240
202012 111.012 109.897 133.113
202103 145.202 111.754 171.216
202106 119.885 114.631 137.816
202109 217.793 115.734 247.981
202112 169.923 117.630 190.359
202203 176.588 121.301 191.838
202206 111.371 125.017 117.393
202209 222.527 125.227 234.166
202212 233.857 125.222 246.098
202303 251.682 127.348 260.434
202306 185.880 128.729 190.280
202309 747.543 129.860 758.577
202312 696.430 129.419 709.112
202403 1,061.975 131.776 1,061.975

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bristol-Myers Squibb Co  (BUE:BMY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bristol-Myers Squibb Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (BUE:BMY) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.